News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
149 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17870)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (247)
2 (234)
3 (123)
4 (6)
5 (2)
6 (157)
7 (294)
8 (215)
9 (227)
10 (147)
11 (6)
12 (2)
13 (213)
14 (201)
15 (161)
16 (149)
17 (68)
19 (2)
20 (132)
21 (113)
22 (70)
23 (4)
24 (6)
26 (9)
27 (154)
28 (186)
29 (127)
30 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
Drug Development
FDA Slaps Breakthrough Tag on Celgene, bluebird’s Multiple Myeloma CAR-T Drug
BTD designation and PRIME eligibility for bb2121 were based on preliminary clinical data from the ongoing phase 1 study CRB-401.
November 16, 2017
·
6 min read
Biotech Bay
Steep Hill Ventures Launched
The company will focus exclusively on funding early stage companies that have the potential of “Advancing the Science of Cannabis?”.
November 16, 2017
·
3 min read
BioMidwest
Invacare Declares Quarterly Dividend - Nov. 16, 2017
The company declared a cash dividend of $.0125 per share on its common shares and $.011364 per share on its Class B common shares payable January 16, 2018.
November 16, 2017
·
1 min read
Business
CSSB and Leica Microsystems Establish an Advanced Light and Fluorescence Microscopy (ALFM) Facility and Integrated Cryo-Imaging Solutions
The partnership, being announced to coincide with the Opening Symposium of the CSSB, will see major collaboration between the two parties for the development of new integrated Cryo-Imaging solutions and the establishment of an advanced microscopy facility.
November 16, 2017
·
2 min read
Drug Development
Vium Announces First Peer-Reviewed Publication for its Digital Vivarium Technology
The peer reviewed paper was published in the journal Frontiers in Pharmacology.
November 16, 2017
·
2 min read
FDA
Voluntis’ Insulia Snags FDA Clearance and CE Mark to Integrate Basaglar and Tresiba
This now makes Insulia available for people using any brand of basal insulin including Lantus, Levemia, Toujeo, Tresiba and Basaglar.
November 16, 2017
·
3 min read
Genetown
AliMed Receives Innovative Technology Designation from Vizient for InvisiCoat Positioners Utilized in Medical Imaging
Designation recognizes products that bring improvements to the healthcare industry.
November 16, 2017
·
2 min read
Business
Philips and Nuance Team to Bring AI Directly Into Radiology Reporting
The initiative will leverage assets from Philips Illumeo with adaptive intelligence and Nuance PowerScribe 360 to help reduce discrepancies, and improve radiology reporting, accuracy and standardization.
November 16, 2017
·
6 min read
Drug Development
Seattle Children’s Opens First CAR T-Cell Immunotherapy Trial in the U.S. for Children and Young Adults With Leukemia that Targets CD22 and CD19 Proteins Simultaneously
With this more robust defense, researchers hope the new experimental therapy, first being investigated in the phase I PLAT-05 trial, will ultimately be able to cut the rate of relapse following CAR T-cell therapy by almost half.
November 16, 2017
·
5 min read
Pharm Country
Canon BioMedical Launches Assays for Spinal Muscular Atrophy Research
The PCR-based method only requires a thermocycler capable of high-resolution melting and a single sample replicate.
November 16, 2017
·
2 min read
Previous
14 of 15
Next